. . . . "clinical trial"@en . . . . . . . . . . . "2014-04-01T00:00:00Z"^^ . . . . "VIABLE"@en . . . . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@en . . . . "ensayu cl\u00EDnicu"@ast . . . . . . . . . . . . . . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . . . "A Randomized, Double Blind, Multicenter, Parallel-group, Phase III Study to Evaluate Efficacy and Safety of DCVAC/PCa Versus Placebo in Men With Metastatic Castration Resistant Prostate Cancer Eligible for 1st Line Chemotherapy"@en . . . . . . . . . . . . . . . "klinisch onderzoek"@nl . . . . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@nl . . . . . . . . . . . . . . . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@nl . . . . . . . . . "NCT02111577" . . . . "18"^^ . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@en . "2019-12-16T00:00:00Z"^^ . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@nl . . . . . . "Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer"@en . . . . . . . . . . "1170"^^ . . . . . . . . . . . . .